Chronic Hepatitis B Recommendations - Australia and New Zealand (2010)
CHB affects over 400 million people worldwide. Acute and chronic HBV infection is a major public health concern in both Australia and New Zealand.
The second edition (2009/10) provides an update on information published on the recognition, diagnosis, and management of patients chronically infected with the hepatitis B virus (HBV).
It is intended to be used as a guide only and not as an authorative statement of every conceivable step or circumstance which may or could relate to the management of chronic hepatitis B.
Specific recommendations are based on relevant published information and will be updated periodically as new information becomes available. This information is due to be revised in 2012/2013.
This clinical update was produced by the Australia and New Zealand CHB Review Panel and The Digestive Health Foundation (DHF) and sponsored by the Gastroenterological Society of Australia with an unrestricted educational grant from Gilead Sciences (Australia and NZ).
Download GESA Clinical Update: Chronic Hepatitis B (CHB) Recommendations - Australia and New Zealand
Download GESA Clinical Update: GESA Chronic Hepatitis B (CHB) Summary and Algorithm